Latest Industry Projects

Ventria Bioscience Announces Expansion of Biomanufacturing and Laboratory Facilities

Ventria Bioscience Announces Expansion of Biomanufacturing and Laboratory Facilities

Introduction:

Ventria Bioscience Inc. plans for expansion of biomanufacturing and laboratory facilities to roughly double Ventria’s capacity for production of recombinant proteins.

Features:

The company broke ground on the expansion of its molecular biology lab, greenhouses, process development and analytical lab, and processing capacity in Junction City, Kansas. Ventria’s proprietary ExpressTec platform for biomanufacturing produces biological products known for purity, safety and cost-effectiveness.

Ventria is developing a promising pipeline of novel therapeutic proteins for potential treatment of human diseases. In addition, Ventria manufactures high-quality, defined, animal-free reagents and cell culture products, marketed globally by its InVitria division and leading laboratory supply distributors. Partnering with pharmaceutical and biotech companies, Ventria also supplies a variety of recombinant proteins for development as potential new drugs.

Construction on the 3,000-square-foot addition to Ventria’s facilities, representing an investment of more than $1.5 million, will begin immediately. Ventria expects its local workforce to grow by more than 50 percent, with several new employees already on board for the expansion.

Specifications:

Name Ventria Bioscience
Location Junction City, Kansas
Type Expansion

 

Source: ventria.com

Other Projects